Jiro Nakayama

Dr. Jiro Nakayama

Kyushu University, Fukuoka, Japan

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2017 in Allergology International
Verified
Journal Article
Open access
MTMasaru Tanaka
Masaru Tanaka
JNJiro Nakayama
Jiro Nakayama
Gut microbial ecology and function are dynamic in infancy, but are stabilized in childhood. The 'new friends' have a great impact on the development of the digestive tract and host immune system. In the first year of life, especially, the gut microbiota dramatically changes through interactions with the developing immune system in the gut. The process of establishing the gut microbiota is affected by various environmental factors, with the potential to be a main determinant of life-long health. In this review, we summarize recent findings regarding gut microbiota establishment, including the importance of various factors related to the development of the immune system and allergic diseases later in life.

1 June 2009 in FEMS Immunology & Medical Microbiology
Verified
Journal Article
Open access
PDF file
STShigemitsu Tanaka
Shigemitsu Tanaka
TKTakako Kobayashi
Takako Kobayashi
PSPrapa Songjinda
Prapa Songjinda
ATAtsushi Tateyama
Atsushi Tateyama
MTMina Tsubouchi
Mina Tsubouchi
JNJiro Nakayama
Jiro Nakayama
The influence of antibiotic exposure in the early postnatal period on the development of intestinal microbiota was monitored in 26 infants including

1 February 2009 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
JNJiro Nakayama
Jiro Nakayama
YUYumi Uemura
Yumi Uemura
KNKenzo Nishiguchi
Kenzo Nishiguchi
NYNorito Yoshimura
Norito Yoshimura
YIYasuhiro Igarashi
Yasuhiro Igarashi
KSKenji Sonomoto
Kenji Sonomoto
Quorum sensing is a cell-density-dependent regulatory system in gram-positive bacteria and is often regulated by cyclic peptides called “quormones,” which function as extracellular communication signals. With an aim to discover an antipathogenic agent targeting quorum sensing in gram-positive bacteria, we screened 153 samples of fungal butanol extracts with the guidance of the inhibition of quorum-sensing-mediated gelatinase production in Enterococcus faecalis . Following the screenings, we found that ambuic acid, a known secondary fungal metabolite, inhibited the quorum-sensing-mediated gelatinase production without influencing the growth of E. faecalis. We further demonstrated that ambuic acid targeted the biosynthesis of a cyclic peptide quormone called gelatinase biosynthesis-activating pheromone. Furthermore, ambuic acid also inhibited the biosynthesis of the cyclic peptide quormones of Staphylococcus aureus and Listeria innocua. These results suggest the potential use of ambuic acid as a lead compound of antipathogenic drugs that target the quorum-sensing-mediated virulence expression of gram-positive bacteria.

1 December 2006 in Journal of Bacteriology
Verified
Journal Article
Closed access
PDF file
JNJiro Nakayama
Jiro Nakayama
SCShengmin Chen
Shengmin Chen
NONozomi Oyama
Nozomi Oyama
KNKenzo Nishiguchi
Kenzo Nishiguchi
EAEssam A. Azab
Essam A. Azab
KSKenji Sonomoto
Kenji Sonomoto
Gelatinase biosynthesis-activating pheromone (GBAP) is an autoinducing peptide involved in Enterococcus faecalis fsr quorum sensing, and its 11-amino-acid sequence has been identified in the C-terminal region of the 242-residue deduced fsrB product (J. Nakayama et al., Mol. Microbiol. 41:145-154, 2001). In this study, however, we demonstrated the existence of fsrD , encoding the GBAP propeptide, which is in frame with fsrB but is translated independently of fsrB . It was also demonstrated that FsrB′, an FsrD segment-truncated FsrB, functions as a cysteine protease-like processing enzyme to generate GBAP from FsrD. This revised model is consistent with the staphylococcal agr system.

1 June 2002 in Applied and Environmental Microbiology
Verified
Journal Article
Open access
PDF file
JNJiro Nakayama
Jiro Nakayama
RKReiko Kariyama
Reiko Kariyama
HKHiromi Kumon
Hiromi Kumon
Expression of virulence-related extracellular proteases, gelatinase, and serine protease of Enterococcus faecalis is regulated by a quorum-sensing system encoded by the fsr gene cluster. In this study, a 23.9-kb chromosomal deletion containing the fsr gene cluster region was found to be present in the majority (79%) of gelatinase-negative clinical isolates of E. faecalis from urine.

15 February 2007 in Journal of Bacteriology
Verified
Journal Article
Open access
PDF file
JNJiro Nakayama
Jiro Nakayama
ETEmi Tanaka
Emi Tanaka
RKReiko Kariyama
Reiko Kariyama
KNKoji Nagata
Koji Nagata
KNKenzo Nishiguchi
Kenzo Nishiguchi
KSKenji Sonomoto
Kenji Sonomoto
The expression of two Enterococcus faecalis virulence-related proteases, gelatinase (GelE) and serine protease (SprE), is positively regulated by a quorum-sensing system encoded by the fsr gene cluster. In this system, E. faecalis secretes an autoinducing peptide, gelatinase biosynthesis-activating pheromone (GBAP), which triggers the FsrC-FsrA two-component regulatory system controlling the expression of two transcripts, fsrBDC and gelE-sprE . In the present study, we screened actinomycete metabolites for inhibitors of fsr quorum sensing. E. faecalis was cultured with each actinomycete culture supernatant tested, and the production of gelatinase and the production of GBAP were examined using the first screening and the second screening, respectively. Culture supernatant of Streptomyces sp. strain Y33-1 had the most potent inhibitory effect on both gelatinase production and GBAP production without inhibiting E. faecalis cell growth. The inhibitor in the culture supernatant was identified as a known peptide antibiotic, siamycin I. Siamycin I inhibited both gelatinase production and GBAP production at submicromolar concentrations, and it inhibited E. faecalis cell growth at concentrations above micromolar concentrations. Quantitative analysis of fsrBDC and gelE-sprE transcripts revealed that siamycin I suppressed the expression of both transcripts at a sublethal concentration. Siamycin I attenuated gelatinase production even when an overdose of GBAP was exogenously added to the culture. These results suggested that siamycin I inhibited the GBAP signaling via the FsrC-FsrA two-component regulatory system in a noncompetitive manner. The sublethal concentrations of siamycin I also attenuated biofilm formation. Treatment with siamycin could be a novel means of treating enterococcal infections.